| PDF (389kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-317691
- DOI to cite this document:
- 10.5283/epub.31769
Abstract
Background Eczema is a common chronic or chronically relapsing skin disease that has a substantial impact on quality of life (QoL). By means of a consensus-based process, the Harmonising Outcome Measures in Eczema (HOME) initiative has identified QoL as one of the four core outcome domains to be assessed in all eczema trials (Allergy 67(9):1111-7, 2012). Various measurement instruments exist to ...

Owner only: item control page
Download Statistics